SLEEP T2D is a feasibility and observational cohort study with a subset of participants included in an RCT of a CE marked medical device used within its intended purpose.
The RCT is a randomised controlled parallel arm trial where participants will be randomised in a 1:1 ratio to CPAP or no CPAP. 140 participants will be randomised.